Our products

Addressing unmet patient needs in oncology

Our medicine is approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. Product availability, name and indication may vary by country. Always ask a healthcare professional for advice about medicines.

To report negative side effects of prescription drugs to the FDA, visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).

USA

KIMMTRAK (tebentafusp-tebn)
(Injection for Intravenous Use 100 mcg/0.5 mL)